UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K
                                    --------

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 Date of Report (Date of earliest event reported): July 17, 2002 (July 2, 2002)


                          Altair Nanotechnologies Inc.
              -----------------------------------------------------
             (Exact name of registrant as specified in its charter)


      Province of
       Ontario,
        Canada                       1-12497                       None
   ----------------           ---------------------         -------------------
   (State or other            (Commission File No.)            (IRS Employer
     jurisdiction                                           Identification No.)
  of incorporation)

                         1725 Sheridan Avenue, Suite 140
                               Cody, Wyoming 82414
          ------------------------------------------------------------
          (Address of principal executive offices, including zip code)

       Registrant's telephone number, including area code: (307) 587-8245


                            Altair International Inc.
                -------------------------------------------------
                   (Former Name, if Changed Since Last Report)

                                       1






Item 5.  Other Events

Name Change
-----------

         The name of our  company  (the  "Company")  has  changed  from  "Altair
International Inc." to "Altair Nanotechnologies Inc." The trading symbol for our
common  shares has not changed,  and  continues to be "ALTI." The purpose of the
name change was to reflect our  strategy of focusing  our business on the supply
of nanomaterials and to reflect the our position in the nanotechnology sector. A
copy of the Articles of Continuance (the  "Articles")  effecting the name change
is attached hereto as Exhibit 3.1

Change of Jurisdiction of Incorporation, Articles and Bylaws.

         In addition to changing the name of the Company, the Articles, together
with the new corporate Bylaw, a copy of which is attached hereto as Exhibit 3.2,
have the following effects:

o        Continuing  (i.e.   redomesticating)  the  Company  from  the  Business
         Corporation Act (Ontario) to Canada's federal corporate statute, called
         the Canada Business Corporations Act,

o        authorizing the directors to appoint one or more  additional  directors
         between  meetings of  shareholders  to hold office for a term  expiring
         until not later than the next annual meeting of shareholders,  provided
         that the total  number of  directors  so  appointed  may not exceed one
         third of the number of directors elected at the previous annual meeting
         of shareholders

o        authorizing  the Company to have  meetings of  shareholders  outside of
         Canada in the State of Nevada, and

o        authorizing  the  board  of  directors  from  time to time  and in such
         amounts and on such terms as it deems  expedient,  to: (i) borrow money
         on the  credit  of  the  Company;  (ii)  issue,  sell  or  pledge  debt
         obligations  (including  bonds,  debentures,  notes  or  other  similar
         obligations,  secured or unsecured)  of the Company;  and (iii) charge,
         mortgage,  hypothecate  or pledge all of any of the currently  owned or
         subsequently acquired real or personal, movable or immovable,  property
         of the Company,  including book debts, rights,  powers,  franchises and
         undertaking,  to secure any debt obligations or any money borrowed,  or
         other debt or liability of the Company.

         Purpose and Effect of Continuance.  The effect of the continuance  (the
"Continuance"),  which would be called a "redomestication"  under most corporate
statutes  in the  United  States,  was to cause the  Company to be  governed  by
Canada's federal corporate statute,  called the Canada Business Corporations Act
(the  "Canadian  Corporate  Code"),  rather  than the  corporate  statute of the
province of Ontario, being the Business Corporations Act (Ontario) (the "Ontario
Corporate  Code").   We  effected  the  Continuance   because  our  business  is
increasingly  being  conducted on an  international  basis,  and  operating as a
Canadian federal company will be more consistent with our  international  focus.
Moreover,  a minimum of 25% of the directors of a company incorporated under the
Canadian  Corporate Code must be resident Canadians whereas 50% of the directors
of a company  incorporated  under the  Ontario  Corporate  Code must be resident
Canadians.  Thus, the Canadian  Corporate  Code's  residency  requirements  will
increase the number of  qualified  nominees for the board from which the Company
may draw.

         Purpose  and  Effect  of  Authorization  of  the  Directors  Respecting
Appointments  to the Board.  Since 1988, our directors  have been  authorized to
determine the size of the board of directors of the Company (the "Board") within
the range set forth in the  Articles,  pursuant to a special  resolution  of the
shareholders  passed June 27, 1988. Such special  resolution did not continue to
apply following the  continuance of the Company to the Canadian  Corporate Code.
In order for the Board to  continue to have the right to  determine  the size of
the Board, within the specified range, an authorizing  provision was required to
appear directly in the Articles.
                                       2


         Purpose of Providing for Meetings Outside of Canada. Under the Canadian
Corporate  Code, a  corporation  may hold  meetings of  shareholders  outside of
Canada if the place of the meetings is specified in its  Articles.  This was not
permitted by the Ontario  Corporate Code. The new Articles provide that meetings
of  shareholders  may take  place in the State of Nevada.  As a majority  of the
Company's  employees  and  officers  are located in Nevada and a large number of
shareholders  of the  Company  are  resident  outside of Canada,  we expect that
holding  meetings in the State of Nevada will be more efficient from both a cost
and timing perspective.

         Purpose of Authorizing  Directors to Conduct Certain Financial Matters.
Under the Ontario  Corporate  Code,  the Board is  automatically  authorized to,
among other things,  borrow money on the credit of the Company,  issue or pledge
debt  obligations  or charge  or  mortgage  property  of the  Company  under the
Company's  by-laws.  For a  company  subject  to the  Canadian  Corporate  Code,
authority to take such  actions  must be expressly  set forth in its articles if
such authority is to be effective in all Canadian jurisdictions. Accordingly, in
order to preserve the Board's authority to (i) borrow money on the credit of the
Company;   (i)  issue,  sell  or  pledge  debt  obligations   (including  bonds,
debentures,  notes or other  similar  obligations,  secured or unsecured) of the
Company;  and (iii) charge,  mortgage,  hypothecate  or pledge all of any of the
currently owned or subsequently acquired real or personal, movable or immovable,
property of the Company,  including book debts, rights,  powers,  franchises and
undertaking, to secure any debt obligations or any money borrowed, or other debt
or liability of the Company,  the Articles include provisions granting the Board
such authority.

         Rights of  Shareholders  under the Canadian  Corporate Code. We believe
that,  except as  described  in this  Current  Report on Form 8-K,  the Canadian
Corporate  Code provides to  shareholders  substantively  the same rights as are
available to shareholders under the Ontario Corporate Code,  including the right
of  dissent  and  appraisal  and the  right  to  bring  derivative  actions  and
oppression actions. The Canadian Corporate Code is consistent with the corporate
legislation in most other Canadian jurisdictions,  and management of the Company
does not consider there to be any material  difference in the respective  rights
of shareholders  thereunder with respect to the  transactions  described  herein
other than  permitting the Company to have meetings of  shareholders  outside of
Canada.

Description of Our Common Shares
--------------------------------

         In connection  with reporting the  Continuance,  the Company desires to
update the  description of its capital stock contained in its Amendment No. 3 to
Form 10 on Form  10-/A  filed with the SEC on March 13,  1997 (the  "Form  10").
Accordingly,  the  information  set  forth  in  Item  11.  "Description  of  the
Registrants  Securities  to be  Registered"  in the Form 10 is  hereby  amended,
restated and superseded by the following:

         The Articles  authorize  the issuance of an unlimited  number of common
shares,  which  do  not  have  par  value.  As of  July  15,  2002,  there  were
24,633,791common  shares issued and  outstanding and held by  approximately  500
registered holders of the Company.  Holders of common shares are entitled to one
vote per share on all  matters to be voted on by  shareholders  of the  Company.
There is no  cumulative  voting with respect to the election of  directors.  The
holders of common  shares are entitled to receive  dividends,  if any, as may be
declared from time to time by the Company's Board of Directors in its discretion
from funds legally available therefor. Upon liquidation,  dissolution or winding
up of the Company,  the holders of common shares are entitled to receive ratably
any assets available for distribution to shareholders. The common shares have no
preemptive or other  subscription  rights, and there are no conversion rights or
redemption or sinking fund  provisions  with respect to such shares.  All of the
outstanding common shares are fully paid and nonassessable.

      As of July 15,  2002,  the Company had issued and  outstanding  options to
acquire  3,941,700  common shares  issued  pursuant to its options plans and had
issued and outstanding  warrants to purchase  4,898,338  common shares issued in
various series.

         Neither  the  Articles  nor the  Bylaws  of the  Company  contains  any
provision that would delay, defer or prevent a change in control of the Company.
The Company has,  however,  adopted  Shareholders  Rights Plan  Agreement  dated
November 27, 1998, amended and restated by the Amended and Restated  Shareholder
Rights Plan Agreement dated October 15, 1999 (the "Rights  Agreement"),  between
the Company and Equity Transfer Services, Inc. (the "Rights Agent").
                                       3


         Pursuant to the Rights  Agreement,  on November  27, 1998 (the  "Record
Date"),  the  Board  authorized  and  declared  a  distribution  of one right (a
"Right") with respect to each common share of the Company issued and outstanding
as of the Record  Date and each  common  share  issued  thereafter  prior to the
Expiration  Time (as  defined  below).  The Rights are  subject to the terms and
conditions  of the Rights  Agreement,  a copy of which is attached as an Exhibit
10.1 to the Current  Report on Form 8-K filed with the SEC on November 18, 1999.
A copy of the Rights  Agreement is also  available  upon written  request to the
Company.  Because it is a summary,  the following  description of the Rights and
the  Rights  Agreement   necessarily   omits  certain  terms,   exceptions,   or
qualifications to the affirmative statements made therein. The reader is advised
to review the entire Rights Agreement prior to making any investment decision.

Certain Key Terms of the Rights Prior to Flip-In Date.

         Prior to the date a  transaction  or event occurs by which a person (an
"Acquiring  Person") becomes the owner of 15% or more of the outstanding  common
shares and other shares entitled to vote for the election of directors  ("Voting
Shares") of the Company (a "Flip-in Event"), each Right shall entitle the holder
thereof to purchase  one-half  common share for the price of $20 (the  "Exercise
Price") (which  Exercise Price and number are subject to adjustment as set forth
in the Rights  Agreement).  Notwithstanding  the  foregoing,  no Right  shall be
exercisable  prior to the "Commencement  Date." The  "Commencement  Date" is the
close of business on the eighth  business  day after the earlier of (a) the date
of a public  announcement or disclosure by the Company or an Acquiring Person of
facts indicating that a person has become an Acquiring  Person,  or (b) the date
of commencement of, or first public announcement of, the intent of any person to
commence  a bid for a number  of  Voting  Shares  that  would  give  the  bidder
beneficial  ownership of 15% of more of the issued and outstanding Voting Shares
(a "Take-over Bid").

Certain Key Terms of the Rights Following Flip-In Date.

         Section  3.1 of  the  Rights  Agreement  (the  "Conversion  Provision")
provides that, subject to certain  exceptions,  upon the occurrence of a Flip-in
Event,  each Right shall be a adjusted so as to  constitute  a right to purchase
from the  Company for the  Exercise  Price a number of common  shares  having an
aggregate "Market Price" of four times the Exercise Price. The "Market Price" is
determined  by averaging  the closing  price of the common shares on the primary
exchange  for the common  shares for the 20 trading days  preceding  the date of
determination.  In addition,  upon the occurrence of any Flip-in Event (which is
not subsequently  deemed not to have occurred under the Rights  Agreement),  any
Rights owned by the  Acquiring  Person,  its  affiliates,  or certain  assignees
become null and void. Any Rights certificate  subsequently issued upon transfer,
exchange,  replacement,  adjustment,  or otherwise with respect to common shares
owned by any of the foregoing  persons shall bear a legend indicating the extent
to which such Rights are void.  Rights  held by the Company or its  subsidiaries
are also void.

Exceptions, Redemption and Waiver.

         The  definitions  of  "Flip-in  Event" and  certain  related  terms are
subject to exceptions,  certain of which are summarized below. Nevertheless,  to
understand  each such  exception  and how they may  interrelate,  the  reader is
advised to review the Rights Agreement. Despite a person's acquisition of 15% or
more of the Voting Shares,  a Flip-in Event shall be deemed not to have occurred
or shall have no effect if:

         (i) the Acquiring Person is the Company or an entity  controlled by the
         Company;

         (ii) the Acquiring  Person is an underwriter who becomes the beneficial
         owner of 15% or more Voting Shares in connection with a distribution of
         securities pursuant to an underwriting agreement with the Company;

         (iii) the  transaction by which the person becomes an Acquiring  Person
         is a "Voting Share Reduction," which is an acquisition or redemption of
         Voting  Shares  by  the  Company  which,  by  reducing  the  number  of
         outstanding  common shares, has the incidental effect of increasing the
         acquiring person's ownership percentage;

                                       4


         (iv) the transaction by which the person becomes an Acquiring Person is
         an  acquisition  with  respect  to  which  the  Board  has  waived  the
         Conversion Provision because:

                  (a) the Board has determined  prior to the  Commencement  Date
                  that a person became an Acquiring Person by inadvertence  and,
                  within 10 days of such determination,  such person has reduced
                  its  beneficial  ownership of common shares so as not to be an
                  Acquiring Person;

                  (b) the Board  acting in good faith has  determined,  prior to
                  the occurrence of a Flip-in Event, to waive application of the
                  Conversion Provision (a "Discretionary Waiver");

                  (c) the Board  determines  within a  specified  time period to
                  waive  application  of the  Conversion  Provision to a Flip-in
                  Event,  provided  that the  Acquiring  Person has reduced,  or
                  agreed to reduce, its beneficial ownership of Voting Shares to
                  less than 15% of the  outstanding  issue of  Voting  Shares (a
                  "Waiver Following Withdrawal").

         (v) the acquisition by which the person becomes an Acquiring  Person is
an acquisition  pursuant to (a) a dividend  reinvestment  plan or share purchase
plan made available to all holders of Voting Shares; (b) a stock dividend, stock
split or similar event pursuant to which the Acquiring  Person  receives  common
shares on pro rata basis with all  members of the same class or series;  (c) the
acquisition or exercise of rights to purchase  Voting Shares  distributed to all
holders of Voting  Shares;  (d) a  distribution  of Voting  Shares or securities
convertible  into Voting Shares offered  pursuant to a prospectus or by way of a
private  placement,  provided the  Acquiring  Person does not thereby  acquire a
greater  percentage of the Voting Shares or convertible  securities offered than
the person's percentage of voting shares beneficially owned immediately prior to
such acquisition.

         In  addition,  (i)  when a  Take-over  Bid is  withdrawn  or  otherwise
terminated after the Commencement Date has occurred, but prior to the occurrence
of a Flip-in  Date, or (ii) if the Board grants a Waiver  Following  Withdrawal,
the  Board  may  elect to  redeem  all  outstanding  Rights at the price of Cdn.
$.0000001  per Right (as adjusted)  (the  "Redemption  Price").  Upon the Rights
being redeemed pursuant to the foregoing provision, all provisions of the Rights
Agreement shall continue to apply as if the Commencement  Date had not occurred,
and the Company shall be deemed to have issued replacement rights to the holders
of its then outstanding common shares.

         In  addition,  the Board  may,  at any time  prior to the first date of
public  announcement  or disclosure by the Company or Acquiring  Person of facts
indicating  that a person  has become an  Acquiring  Person  (the  "Announcement
Date")  elect to redeem  all,  but not less than  all,  of the then  outstanding
Rights at the Redemption Price  ("Discretionary  Redemption").  Moreover, in the
event a person acquires Voting Shares  pursuant to a Discretionary  Waiver,  the
Board  shall be deemed to have  elected to redeem  the Rights at the  Redemption
Price ("Deemed Redemption"). Within 10 days after the Board elects, or is deemed
to have elected, to redeem the Rights, the Board shall give notice of redemption
to the holders of the then outstanding Rights and, in such notice, described the
method of payment by which the redemption  price will be paid. The rights of any
person under the Rights Agreement or any Right, except rights to receive cash or
other  property  that have  already  accrued,  shall  terminate on the date of a
Discretionary Redemption or a Deemed Redemption (the "Expiration Time").

Exercise of the Rights.

           The Rights shall not be exercisable  prior to the Commencement  Date.
Until the  Commencement  Date,  each Right shall be evidenced by the certificate
for the associated common share and will be transferable only together with, and
will be transferred by the transfer of, its associated  common share. New common
share certificates  issued after the effective date of the Rights Agreement will
contain a legend  incorporating the Rights Agreement by reference.  Certificates

                                       6



issued and  outstanding  at the  effective  date of the Rights  Agreement  shall
evidence one Right for each common share evidenced thereby,  notwithstanding the
absence of a legend incorporating the Rights Agreement, until the earlier of the
Commencement Date or the Expiration Time. Each common share issued for new value
after the effective  date of the Rights  Agreement,  but prior to the Expiration
Time, shall  automatically  have one new Right associated with it and shall bear
the appropriate legend.

         From and after the Commencement Date, the Rights may be exercised,  and
the  registration  and  transfer  of the  Rights  shall  be  separate  from  and
independent of the common shares.  Following the Commencement  Date, the Company
shall mail to each holder of common shares as of the Commencement  Date, or such
holder's nominee, a Rights Certificate representing the number of Rights held by
such holder at the Commencement Date and a disclosure  statement  describing the
Rights.

         Rights may be  exercised  in whole or in part on any business day after
the  Commencement  Date and prior to the  Expiration  Time by  submitting to the
Rights Certificate, an election to exercise, and payment of the sum equal to the
Exercise Price multiplied by the number of Rights being exercised.  Upon receipt
of  such  materials,   the  Rights  Agent  will  promptly  deliver  certificates
representing the appropriate number of common shares to the registered holder of
the relevant Rights  Certificate and, if not all Rights were exercised,  issue a
new Rights Certificate evidencing the remaining unexercised Rights.

         The  foregoing  descriptions  do not  purport  to be  complete  and are
qualified by reference to the definitive Rights Agreement.

Item 7.  Financial Statements and Exhibits

         (c)      Exhibits.




  Exhibit No.                         Exhibit          Incorporated by Reference/ Filed Herewith
----------------    -----------------------------   ------------------------------------------------

                                              
            3.1     Articles of Continuance         Filed herewith.


            4.2     Bylaw No. 1                     Filed herewith.



                                       7



                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly caused this Current Report on Form 8-K to be signed on
its behalf by the undersigned thereunto duly authorized.

                                 Altair Nanotechnologies Inc.


July 17, 2002             By: /s/ William P. Long
  Date                        ------------------------------------------------
                                  Dr. William P. Long, Chief Executive Officer


                                       8